Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$223M |
| 2 |
CVS Health
CVS
|
+$18.9M |
| 3 |
American International
AIG
|
+$16.3M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$13.4M |
| 5 |
TJX Companies
TJX
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$12.6M |
| 2 |
Crown Castle
CCI
|
+$7.91M |
| 3 |
Eli Lilly
LLY
|
+$7.58M |
| 4 |
RTX Corp
RTX
|
+$7.28M |
| 5 |
Deere & Co
DE
|
+$7.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.16% |
| 2 | Consumer Discretionary | 11.77% |
| 3 | Financials | 11.5% |
| 4 | Healthcare | 9.84% |
| 5 | Technology | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FENX
1026
DELISTED
Fenix Parts, Inc.
FENX
| $49K | ﹤0.01% |
+12,423
| New | +$52.6K |
2016 Q2
0 quarters
|
|
1027
Harmonic Inc
HLIT
$1.15B
| $48K | ﹤0.01% |
16,700
+2,200
| +15% | +$6.74K |
2016 Q1
1 quarter
|
|
1028
Verastem
VSTM
$1.19B
| $48K | ﹤0.01% |
+3,067
| New | +$54K |
2016 Q2
0 quarters
|
|
1029
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
| $48K | ﹤0.01% |
14,600
-2,600
| -15% | -$7.1K |
2015 Q4
2 quarters
|
|
1030
Celldex Therapeutics
CLDX
$2.34B
| $47K | ﹤0.01% |
713
-4,447
| -86% | -$282K |
2016 Q1
1 quarter
|
|
1031
Tronox
TROX
$553M
| $47K | ﹤0.01% |
+10,600
| New | +$60.1K |
2016 Q2
0 quarters
|
|
|
MRIN
1032
DELISTED
Marin Software
MRIN
| $46K | ﹤0.01% |
+462
| New | +$49.3K |
2016 Q2
0 quarters
|
|
1033
Zedge
ZDGE
$37.9M
| $46K | ﹤0.01% |
+10,128
| New | +$42.4K |
2016 Q2
0 quarters
|
|
1034
DELISTED
Affimed
AFMD
| $44K | ﹤0.01% |
+1,760
| New | +$64.3K |
2016 Q2
0 quarters
|
|
|
IMBI
1035
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $44K | ﹤0.01% |
+2,660
| New | +$37.7K |
2016 Q2
0 quarters
|
|
1036
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $42K | ﹤0.01% |
+16,486
| New | +$46K |
2016 Q2
0 quarters
|
|
1037
DELISTED
Molecular Templates, Inc.
MTEM
| $41K | ﹤0.01% |
+395
| New | +$28.3K |
2016 Q2
0 quarters
|
|
|
VMEM
1038
DELISTED
VIOLIN MEMORY, INC.
VMEM
| $41K | ﹤0.01% |
+11,075
| New | +$22.8K |
2016 Q2
0 quarters
|
|
1039
DELISTED
VOXX International Corporation Class A
VOXX
| $40K | ﹤0.01% |
+14,200
| New | +$52.8K |
2016 Q2
0 quarters
|
|
|
CHMA
1040
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $40K | ﹤0.01% |
+13,900
| New | +$61.2K |
2016 Q2
0 quarters
|
|
|
VSLR
1041
DELISTED
VIVINT SOLAR, INC.
VSLR
| $39K | ﹤0.01% |
+12,767
| New | +$37.6K |
2016 Q2
0 quarters
|
|
|
FCSC
1042
DELISTED
Fibrocell Science Inc.
FCSC
| $38K | ﹤0.01% |
+2,220
| New | +$69.1K |
2016 Q2
0 quarters
|
|
|
RTK
1043
DELISTED
Rentech, Inc.
RTK
| $37K | ﹤0.01% |
+15,400
| New | +$45.5K |
2016 Q2
0 quarters
|
|
1044
Digital Turbine
APPS
$1.14B
| $35K | ﹤0.01% |
+32,900
| New | +$32.2K |
2016 Q2
0 quarters
|
|
1045
aTyr Pharma
ATYR
$16.4M
| $34K | ﹤0.01% |
+22
| New | +$40.9K |
2016 Q2
0 quarters
|
|
1046
Harvard Bioscience
HBIO
$39.7M
| $32K | ﹤0.01% |
+1,120
| New | +$35.6K |
2016 Q2
0 quarters
|
|
|
CTIC
1047
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $32K | ﹤0.01% |
+9,370
| New | +$43K |
2016 Q2
0 quarters
|
|
1048
DELISTED
Alimera Sciences
ALIM
| $31K | ﹤0.01% |
+1,687
| New | +$44.9K |
2016 Q2
0 quarters
|
|
1049
DELISTED
Catalyst Pharmaceutical
CPRX
| $29K | ﹤0.01% |
+41,400
| New | +$33.3K |
2016 Q2
0 quarters
|
|
1050
Inseego
INSG
$79.1M
| $27K | ﹤0.01% |
+1,760
| New | +$27K |
2016 Q2
0 quarters
|
|
Similar funds
Squarepoint's Q2 2016 Portfolio in Review
As of Q2 2016, Squarepoint held 1,549 positions worth $1.6B, up 24% from $1.29B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Squarepoint deployed $307M of net new capital in Q2 2016, opening 435 new positions and adding to 314 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 833,964 shares worth $227M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 2.8% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Crown Castle, an estimated $7.91M trimmed.
- Squarepoint's largest Q2 2016 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 833,964 shares worth $227M.
- Squarepoint added most to CVS Health in Q2 2016, an estimated $18.9M increase.
- Squarepoint's biggest Q2 2016 reduction was Crown Castle, cutting an estimated $7.91M.
- Squarepoint fully exited Chubb in Q2 2016, selling an estimated $12.6M.
- Squarepoint's ten largest holdings make up 23% of its $1.6B portfolio in Q2 2016.
- Squarepoint opened 435 new positions and closed 482 in Q2 2016.
- Squarepoint's portfolio value rose 24% quarter-over-quarter to $1.6B.
Based on Squarepoint's 13F filing for Q2 2016, filed 15 Aug 2016.